Cargando…

Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy

INTRODUCTION: Colorectal cancer is one of the most common gastrointestinal cancers and the second leading cause of cancer-related death. Although colonoscopy screening has greatly improved the early diagnosis of colorectal cancer, its recurrence and metastasis are still significant problems. Tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xi, Sun, Yiwen, Song, Jia, Huang, Yusong, Shi, Huizhong, Qian, Aihua, Cao, Yuncan, Zhou, Youci, Wang, Qijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693327/ https://www.ncbi.nlm.nih.gov/pubmed/38045683 http://dx.doi.org/10.3389/fimmu.2023.1301452

Ejemplares similares

Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2021)

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2020)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023)

It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
por: Yao, Shiya, et al.
Publicado: (2023)

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma
por: Liang, Zhongqing, et al.
Publicado: (2022)

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies
por: Chen, Lei, et al.
Publicado: (2022)

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
por: Shi, Junhong, et al.
Publicado: (2021)

Roles and therapeutic implications of m6A modification in cancer immunotherapy
por: Pan, Juan, et al.
Publicado: (2023)

Colorectal Cancer Immunotherapy: Options and Strategies
por: Johdi, Nor Adzimah, et al.
Publicado: (2020)

Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
por: Wang, Ding-Kang, et al.
Publicado: (2021)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy
por: Hua, Hanju, et al.
Publicado: (2023)

PathwayKO: An integrated platform for deciphering the systems-level signaling pathways
por: Ai, Hannan, et al.
Publicado: (2023)

Complement System: An Immunotherapy Target in Colorectal Cancer
por: Talaat, Iman M., et al.
Publicado: (2022)

Mechanism and strategies of immunotherapy resistance in colorectal cancer
por: Shan, Jiqi, et al.
Publicado: (2022)

Endostatin induces normalization of blood vessels in colorectal cancer and promotes infiltration of CD8+ T cells to improve anti-PD-L1 immunotherapy
por: Chu, Xiao-Dong, et al.
Publicado: (2022)

Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer
por: Xiong, Qiao, et al.
Publicado: (2022)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration
por: Xie, Hailun, et al.
Publicado: (2023)

CAR T-cells for colorectal cancer immunotherapy: Ready to go?
por: Ghazi, Bouchra, et al.
Publicado: (2022)

CASP-Model Sepsis Triggers Systemic Innate Immune Responses Revealed by the Systems-Level Signaling Pathways
por: Ai, Hannan, et al.
Publicado: (2022)

Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer
por: Xu, Wenhao, et al.
Publicado: (2022)

Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment
por: Zheng, Xiaoyong, et al.
Publicado: (2022)

Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
por: Lin, Fei, et al.
Publicado: (2023)

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
por: Huang, Da, et al.
Publicado: (2022)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

NK Cell Metabolism and TGFβ – Implications for Immunotherapy
por: Slattery, Karen, et al.
Publicado: (2019)

An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer
por: Wang, Ke-wei, et al.
Publicado: (2022)

The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma
por: Ye, Ting, et al.
Publicado: (2022)

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer
por: Crupi, Mathieu J. F., et al.
Publicado: (2022)

Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
por: Ghiringhelli, François, et al.
Publicado: (2019)

Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer
por: Hou, Xinxin, et al.
Publicado: (2022)

Immunotherapies catering to the unmet medical need of cold colorectal cancer
por: Yuan, Jun, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
por: Zhou, Long, et al.
Publicado: (2023)

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
por: Ibis, Betul, et al.
Publicado: (2023)

The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers
por: Yu, Aoyang, et al.
Publicado: (2023)

Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer
por: Zhang, Xiaojun, et al.
Publicado: (2023)

A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer
por: Wang, Xu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kk7ogi2hg9n2jitirfsvqc6n4j